Effects of two inhibitors of renin-angiotensin system on attenuation of postoperative remodeling after left ventricular aneurysm repair in rats

Journal of Cardiac Surgery

Volumn 18, Issue SUPPL. 2, 2003, Pages

  Nomoto, Takuya ^a   Nishina, Takeshi ^a   Tsuneyoshi, Hiroshi ^a   Miwa, Senri ^a   Nishimura, Kazunobu ^a   Komeda, Masashi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; RENIN;

ACUTE HEART INFARCTION; ANEURYSM SURGERY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE VOLUME; HEART LEFT VENTRICLE WALL MOTION; HEART VENTRICLE ANEURYSM; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; MALE; NONHUMAN; POSTOPERATIVE CARE; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; HEART ANEURYSM; HEART CATHETERIZATION; HEART VENTRICLES; HEMODYNAMIC PROCESSES; LISINOPRIL; MALE; MYOCARDIAL INFARCTION; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; TETRAZOLES; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 0042855828     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8191.18.s2.9.x     Document Type: Conference Paper

References (24)

1. Komeda M, David TE, Malik A, et al: Operative risk and long-term results of operation for left ventricular aneurysm. Ann Thorac Surg 1992;53:22-29.
2. Di Donato M, Barletta G, Maioli M, et al: Early hemodynamic results of left ventricular reconstructive surgery for anterior wall left ventricular aneurysm. Am J Cardiol 1992;69:886-890.
3. Mickleborough LL, Carson S, Ivanov J: Repair of dyskinetic or akinetic left ventricular aneurysm: results obtained with a modified linear closure. J Thorac Cardiovasc Surg 2001;121:675-682.
4. Dor V, Sabatier M, Di Donato M, et al: Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: Comparison with a series of large dyskinetic scars. J Thorac Cardiovasc Surg 1998;116:50-59.
5. Sinatra R, Macrina F, Braccio M, et al: Left ventricular aneurysmectomy; comparison between two techniques; early and late results. Eur J Cardiothorac Surg 1997;12:291-297.
6. Nishina T, Nishimura K, Yuasa S, et al: A rat model of ischemic cardiomyopathy for investigating left ventricular volume reduction surgery. J Card Surg 2002;17:155-162.
7. Nishina T, Nishimura K, Yuasa S, et al: Initial effects of the left ventricular repair by plication may not last long in a rat ischemic cardiomyopathy model. Circulation 2001;104[suppl 1]:1-2411-245.
8. Ratcliffe MB, Wallace AW, Salahieh A, et al: Ventricular volume, chamber stiffness, and function after anteroapical aneurysm plication in the sheep. J Thorac Cardiovasc Surg 2000;119:115-124.
9. Richer C, Mulder P, Fornes P, et al: Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats. J Cardiovasc Pharmacol 1992;20:147-156.
10. Yoshiyama M, Takeuchi K, Omura et al: Effects of candesartan and cilazapril on rats with myocardial infarction assessed by echocardiography. Hypertension 1999;33:961-968.
11. Schnee JM, Hsueh WA: Angiotensin II, adhesion, and cardiac fibrosis. Cardiovasc Res 2000;46:264-268.
12. van Kats JP, Duncker DJ, Haitsma DB, et al: Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II. Circulation 2000;102:1556-1563.
13. Schiller NB, Shah PM, Crawford M, et al: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-367.
14. Takuma S, Suehiro K, Cardinale C, et al: Anesthetic inhibition in ischemic and nonischemic murine heart: comparison with conscious echocardiographic approach. Am J Physiol Heart Circ Physiol 2001;280:H2364-H2370.
15. Suga H, Sagawa K: Instantaneous pressure-volume relationships and their ratio in the excised, supported canine left ventricle. Circ Res 1974;35:117-126.
16. Sam F, Sawyer DB, Chang DLF, et al: Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol Heart Circ Physiol 2000;279:H422-H428.
17. Kjoller-Hansen L, Steffensen R, Grande P: Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes after uncomplicated invasive revascularization are associated with a reduction in cardiac events in patients with moderately impaired left ventricular function and no clinical heart failure. Am Coll Cardiol 2001;37:1214-1220.
18. Pfeffer M, Braunwald E, Moye L, et al: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992;327:669-677.
19. Urata H, Nishimura H, Ganten D: Chymase-dependent angiotensin II forming systems in humans. Am J Hypertens 1996;9:277-284.
20. Biollaz J, Btunner HR, Gavras I, et al: Antihypertensive therapy with MK-421: Angiotensin II-renin relationships to evaluate efficacy of converting enzyme blockade. J Cardiovasc Pharmacol 1982;4:966-972.
21. Hu K, Gaudron P, Anders HJ, et al: Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: Role of bradykinin. Cardiovasc Res 1998;39:401-412.
22. Pitt B, Poole-Wilson PA, Segal R, et al: Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial - The Losartan Heart Failure Survival Study ELITE II. Lancet 2000;355:1582-1587.
23. Wollert KC, Drexler H: The renin-angiotensin system and experimental heart failure. Cardiovasc Res 1999;43:838-849.
24. Yu CM, Tipoe GL, Lai KWH, et al: Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction. J Am Coll Cardiol 2001;38:1207-1215.